Top Story

Atezolizumab plus bevacizumab extends survival in unresectable HCC

December 3, 2019
FDA News

FDA grants priority review to pemigatinib for cholangiocarcinoma

November 27, 2019
The FDA granted priority review to pemigatinib for the treatment of patients with previously treated, locally advanced or metastatic cholangiocarcinoma and FGFR2
Meeting NewsVideo

VIDEO: Blood-based panel detects early-stage liver cancer

November 13, 2019
BOSTON — In this exclusive video from The Liver Meeting 2019, Naga P. Chalasani, MD, from the Indiana University School of Medicine, discusses the accuracy of…
In the Journals

New treatment approaches induce responses in unresectable intrahepatic cholangiocarcinoma

November 6, 2019
Chemotherapy combined with hepatic arterial infusion of floxuridine or with selective internal radiotherapy induced antitumor activity among patients with unresectable…
More Headlines »